Your browser doesn't support javascript.
loading
The impact of the host intestinal microbiome on carcinogenesis and the response to chemotherapy.
Wertman, Jaime N; Dunn, Katherine A; Kulkarni, Ketan.
Afiliación
  • Wertman JN; Department of Pediatrics/Division of Pediatric Hematology-Oncology, Dalhousie University/IWK Health Centre, Halifax, Canada.
  • Dunn KA; College of Pharmacy, Dalhousie University, Halifax, Canada.
  • Kulkarni K; Department of Pediatrics/Division of Pediatric Hematology-Oncology, Dalhousie University/IWK Health Centre, Halifax, Canada.
Future Oncol ; 17(32): 4371-4387, 2021 Nov.
Article en En | MEDLINE | ID: mdl-34448411
Lay abstract The microbiome describes all of the microorganisms (including bacteria, viruses and fungi) that are normally present on and inside the human body. Some diseases, including cancer, can be caused or worsened by an 'unbalanced' or 'unhealthy' gut microbiome. Some drugs that are given to people who have cancer can change the microbiome. Importantly, components of the gut microbiome can also change how a cancer drug will work in someone. We can change the microbiome in certain ways, like by giving someone antibiotics. Understanding how the microbiome influences the way anticancer drugs work is important because it could help us understand how to make cancer treatment safer and more effective. This review article summarizes available research on the impact of the microbiome on cancer treatment.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Microbioma Gastrointestinal / Neoplasias Límite: Humans Idioma: En Revista: Future Oncol Año: 2021 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Microbioma Gastrointestinal / Neoplasias Límite: Humans Idioma: En Revista: Future Oncol Año: 2021 Tipo del documento: Article País de afiliación: Canadá